Edit |   |
---|---|
Antigenic Specificity | APP Abeta, Human (Solanezumab biosimilar) |
Clone | Solanezumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human APP Abeta Recombinant Antibody (Solanezumab). Solanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5] |
Immunogen | n/a |
Other Names | Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab, Anti-Human APP Abeta Recombinant Antibody(Solanezumab), LY2062430, Antibody Drug Analogues, Monoclonal Antibody, YR1197, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 955085-14-0 |
Catalog # | YR1197 |
Price | please inquire |
Order / More Info | APP Abeta, Human (Solanezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |